HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

PLYMOUTH MEETING, Pa., Aug. 17, 2022 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (NASDAQ: HRMY), a pharmaceutical company focused on delivering innovative therapies that improve the health of people living with rare neurological diseases, today…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.